Acral Lentiginous Malignant Melanoma
5 clinical trials · Condition
◉ Watch Acral Lentiginous Malignant Melanoma
| Record | Firm | Date |
|---|---|---|
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma (NCT01120275) | National Cancer Institute (NCI) | 2010-10-01 |
| A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread (NCT01395121) | Institute of Cancer Research, United Kingdom | 2009-12-01 |
| SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma (NCT00577382) | Dana-Farber Cancer Institute | 2007-08-01 |
| Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery (NCT00470470) | National Cancer Institute (NCI) | 2007-04-01 |
| AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma (NCT00243061) | National Cancer Institute (NCI) | 2006-01-01 |
Track Acral Lentiginous Malignant Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.